Showing results (1-10 of 356) with videos related to
Sort By:
Pageof 36
International Journal of Cancer|December 24, 2025
Immunotherapy in advanced gastroesophageal cancers: A meta-analysis of sex-based outcomes in overall survivalMichael Masetti, Fausto Petrelli, Filippo Pietrantonio, et al.Pharmacogenomics|July 26, 2018
Genomic markers of resistance to targeted treatments in gastric cancer: potential new treatment strategiesAlessandra Raimondi, Federico Nichetti, Giorgia Peverelli, et al.JAMA Oncology|December 8, 2022
Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1 SubgroupsDominic Wei Ting Yap, Alberto Giovanni Leone, Nicky Zhun Hong Wong, et al.Recenti Progressi in Medicina|December 20, 2018
[Perioperative treatment with FOLFIRI plus aflibercept in a patient with RAS and BRAF wild-type, left-sided colon cancer, with early relapse following adjuvant oxaliplatin- based treatment due to potentially resectable liver metastases]Filippo PietrantonioRecenti Progressi in Medicina|December 20, 2018
[Second-line treatment with FOLFIRI plus aflibercept in a patient with right-sided, BRAF mutated metastatic colon cancer.]Filippo PietrantonioRecenti Progressi in Medicina|December 20, 2018
[Treatment with FOLFIRI plus aflibercept in a patient with RAS and BRAF wild-type, right-sided colon cancer and potentially resectable liver metastases]Filippo PietrantonioBritish Journal of Cancer|November 23, 2021
Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino studyPaolo Manca, Salvatore Corallo, Sara Lonardi, et al.Tumori|September 21, 2016
How the lab is changing our view of colorectal cancerChiara Cremolini, Filippo PietrantonioClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2023
Towards Multiomics-Based Dissection of Anti-EGFR Sensitivity in Colorectal CancerGiovanni Randon, Filippo PietrantonioMed (New York, N.Y.)|June 12, 2026
Chemoimmunotherapy enables adaptive strategies in locally advanced MSS colorectal cancerFilippo Ghelardi, Filippo PietrantonioPageof 36